rop

Because the source data doesn't disclose named segment revenue, the best-supported revenue drivers are company-wide operating levers rather than product-level line items. First, the reported 2025 revenue base of $7.90B expanded 12.3% YoY, which is strong growth for a mature large-cap software-oriented portfolio and indicates that the acquired-business mix is still compounding. Second, operating income reached $2.24B on that base, showing that growth is translating into meaningful absolute profit dollars rather than just scale for its own sake...

On the available evidence, this market is best classified as semi-contestable rather than fully non-contestable. The company’s 69.2% gross margin, 28.3% operating margin, and 100 earnings predictability all indicate meaningful franchise protection, but the Source data doesn't show the core Greenwald proof points needed to call it non-contestable: direct evidence of customer captivity, market share by product, or a barrier that clearly prevents a capable entrant from matching both cost structure and demand capture. Could a new entrant replicate the incumbent’s cost structure?...

The cost structure shows meaningful fixed-cost intensity: R&D was $852.5M in 2025, SG&A was $3.24B, and those two lines together imply a large overhead base that must be spread over volume. That's exactly the kind of structure where scale matters, especially when gross margin is already 69.2% and operating margin remains 28.3% even after continued investment. The company is therefore benefiting from scale, but scale alone is not a moat unless it also suppresses entrant demand...

Using the audited 2025 income statement as the only fully verifiable demand base, the cleanest bottom-up proxy for ROP’s current addressable footprint is $7.06B in revenue, derived from $5.47B gross profit plus $2.43B cost of revenue. That'sn't a formal enterprise TAM, but it's the best observable lower bound on the market ROP is currently penetrating. For forward context, the institutional survey projects Revenue/Share of $80.95 in 2026 versus $73.85 in 2025E, which implies continued expansion per share...

Roper’s current penetration rate can't be calculated in a strict sense because the source data doesn't provide an external market denominator, segment revenue mix, or end-market unit counts. What can be measured is the company’s internal share of the observable revenue base: the enterprise generated about $7.06B of revenue in 2025 and maintained 69.2% gross margin, 28.3% operating margin, and 19.4% net margin, which is consistent with strong monetization inside niche markets...

Roper’s technology stack appears to be a mix of proprietary application workflows, acquired software capabilities, and supporting commercial infrastructure rather than a single monolithic architecture. The strongest evidence is economic: R&D expense reached $852.5M in 2025, yet the business still produced 69.2% gross margin and 28.3% operating margin, which is consistent with a platform that can absorb continual feature development while preserving pricing power. What looks proprietary from the outside is less the underlying infrastructure and more the embedded domain workflow, data model, and installed-base integration depth...

The available data doesn't provide named product launches or a dated roadmap, so the R&D pipeline has to be inferred from spending trends and capital allocation. The clearest signal is that R&D increased from $646.1M in 2023 to $748.1M in 2024 and then to $852.5M in 2025, indicating a persistent cadence of product refresh, feature enhancement, and platform maintenance rather than a one-off development burst. From an investment perspective, the key question is not whether Roper is spending enough to keep products current; it clearly is...

The moat appears to be more commercial and structural than patent-driven. The available data does not disclose a patent count, trade-secret inventory, or formal years of protection, so any precise IP tally is n/a. Even so, the financial profile suggests a defensible asset base: gross margin of 69.2%, earnings predictability of 100, and safety rank of 1 point to a business with recurring, resilient demand characteristics rather than a commoditized software vendor...

There's no supplier concentration disclosure in the Source data, so the direct vendor map is n/a. That said, the operating profile argues the bigger concentration risk is not a classic single supplier of raw materials; it's a portfolio-level dependence on a consistent, repeatable operating platform that can sustain 69.2% gross margin and 28.3% operating margin. The balance sheet suggests the real single point of failure is execution across an acquisition-heavy structure: goodwill reached $21.34B and long-term debt rose to $9.30B in 2025...

The Source data doesn't disclose country-by-country sourcing, manufacturing, or logistics locations, so specific regional dependency percentages aren't disclosed. Because of that, the most defensible geographic-risk view is that Roper’s exposure is likely indirect and embedded in software, services, and acquisition footprints rather than in heavy physical manufacturing...

The most immediate catalyst is continued execution against the company’s 2025 operating base, where revenue growth reached +12.3% and operating margin held at 28.3% despite SG&A still representing 41.0% of revenue. The audited income statement shows operating income rising to $2.24B in 2025, up from $525.8M in the first quarter, while quarterly net income reached $398.5M in the third quarter and $1.54B for the full year. That combination suggests the core question for investors is not simply growth, but the durability of margin conversion as the company scales its software-led portfolio...

Capital allocation is a meaningful catalyst because Roper’s 2025 balance sheet shows both substantial earning power and a heavier debt load than two years earlier. Long-term debt increased to $9.30B in 2025 from $7.62B in 2024 and $6.33B in 2023, while shareholders’ equity stood at $19.88B and total liabilities at $14.70B. On a book basis, debt-to-equity is 0.74, while the computed debt-to-equity ratio in the model is 0.47...

For a company like Roper, estimate revisions can be as important a catalyst as headline growth because the stock’s long-term value case depends on compounding at the per-share level. The institutional survey already embeds that logic: Revenue/Share rises from $57.79 in 2023 to $65.61 in 2024 and an estimated $73.85 in 2025, with another step to $80.95 in 2026. EPS follows a similar path, from $16.71 in 2023 to $18.32 in 2024, then to an estimated $20.00 in 2025 and $21.75 in 2026...

STREET SAYS: Roper deserves a premium multiple, but not necessarily a full re-rating yet; the market appears to be discounting a softer long-run EPS path and is comfortable valuing the company near the current $367.34 share price. In the evidence set, the market-implied reverse DCF points to -4.8% growth, which is effectively a no-growth stance. WE SAY: The audited 2025 profile supports a meaningfully higher fair value because revenue still grew +12.3%, gross margin was 69.2%, operating margin was 28.3%, and operating cash flow was $2.5403B...

The evidence set doesn't provide a full sell-side revision history, so the cleanest observable trend comes from the company’s own 2025 audited results versus the longer-duration institutional view. Near term, the revision signal is effectively flat-to-down on earnings because audited diluted EPS finished at $14.20 with -1.0% YoY growth, even as revenue grew +12.3%. That mismatch tells us what Street revisions are probably debating: whether the next leg of the model shows operating scale effect from a 69.2% gross margin base and 2.5403B of operating cash flow, or whether SG&A at 41.0% of revenue keeps EPS revisions muted...

Roper’s earnings profile looks fundamentally strong on the measures that matter most for quality: 2025 gross margin was 69.2%, operating margin was 28.3%, and net margin was 19.4%. Cash generation also supports the story, with $2.54B of operating cash flow against $1.54B of net income, implying healthy cash conversion at the annual level. Those are the hallmarks of a business that can absorb reinvestment without collapsing profitability...

The available data doesn't include a 90-day analyst revision history, so the direction and magnitude of near-term estimate revisions can't be measured directly here. What we can say is that the market-facing reference points are already pulling in different directions: audited 2025 diluted EPS is $14.20, while the institutional survey’s 2025 EPS estimate is $20.00 and its 2026 estimate is $21.75. That gap implies either the survey is looking through temporary margin pressure or it's embedding a more aggressive operating trajectory than the audited base supports...

Within the supplied source data, there are no direct job-posting, web-traffic, app-download, patent, or social-media series, so we can't manufacture a directional read from those channels. That absence itself is important: the current pane is being driven by audited financials and market pricing rather than high-frequency alternative datasets. What we can cross-check is the operating footprint implied by the 2025 filings: revenue growth of +12.3%, gross margin of 69.2%, and EBITDA of $3.13B are consistent with a business still expanding without obvious evidence of demand collapse...

Retail/institutional sentiment is best approximated here by the live market price, reverse DCF, and the independent survey. The stock trades at $367.34 versus a model fair value of $395.00, while the survey’s 3-5 year target range of $690.00-$845.00 sits far above the tape. That combination suggests sentiment is cautious to skeptical even though the long-run earnings framework remains constructive...

Roper’s management profile looks like a classic high-quality compounder: the company produced 69.2% gross margin, 28.3% operating margin, and $2.5403B of operating cash flow in 2025, while revenue grew +12.3% year over year. That combination supports the view that leadership is preserving a durable economic moat through pricing discipline, portfolio quality, and cost control. The 2025 quarterly cadence also improved through the year, with operating income rising from $525.8M in Q1 to $573.0M in Q3, which argues execution is more than stable but improving...

The Source data doesn't include board composition, committee independence, director elections, or proxy-voting structure, so governance quality can't be fully verified from EDGAR facts here. On the financial side, the firm’s capital structure remains manageable relative to earnings power: interest coverage is 13.6, debt-to-equity is 0.47, and total liabilities-to-equity is 0.74. That suggests governance hasn't obviously allowed balance-sheet drift to become destabilizing, but it doesn't prove strong shareholder protections...

Compensation alignment can't be confirmed because the Source data contains no DEF 14A, incentive-plan, or realized-pay disclosures. That said, the operating results provide a partial read-through: 2025 revenue growth was +12.3%, operating margin was 28.3%, and operating cash flow was $2.5403B, which is the kind of performance typically rewarded in a shareholder-friendly pay program. The problem is that EPS growth was still -1.0% YoY, so a pay plan that shows revenue or EBITDA alone would be insufficiently aligned...

Roper’s macro profile is unusually sensitive to interest rates because the stock’s valuation is driven by long-duration cash flows rather than near-term balance-sheet stress. The deterministic DCF outputs a $750.24 per-share fair value at 7.5% WACC, with bull and bear outcomes of $1,252.19 and $388.26, respectively. Against the current price of $353.48, the market is effectively discounting a much harsher capital-cost regime than the base model...

The provided data don't disclose key input commodities, supplier concentration, or a COGS bridge that would let us quantify raw-material sensitivity. What is clear is that 2025 cost of revenue was $2.43B against gross profit of $5.47B, producing a 69.2% gross margin; that profile is more consistent with a software- and IP-heavy business than a commodity-intensive manufacturer. Because no commodity basket or hedging policy is supplied in the Source data, the most defensible conclusion is that commodity risk is likely secondary to pricing, mix, and acquisition-related operating scale effect...

The Source data doesn't provide product-level tariff exposure, China sourcing dependence, or a regional supply-chain map, so trade policy can't be quantified with precision. That said, the business’s 2025 financial profile, $5.47B gross profit, 69.2% gross margin, and $852.5M of R&D expense, suggests an asset-light, software-oriented model that's typically less exposed to tariff shocks than industrial or hardware peers. The practical risk is indirect: if any acquired business relies on international subcontracting or hardware-adjacent distribution, tariff pressure could flow into margins rather than revenue...

Roper’s liquidity picture is best described as institutional-grade at the share level but thin on balance-sheet cash. The Source data provides 106.6M shares outstanding and a live market cap of $36.38B, but it doesn't include average daily volume, bid-ask spread, institutional turnover, or a block-trade impact model. So, any precise market-impact estimate would be speculative and is not shown as a fabricated number...

Technical indicators aren't populated in the Source data, so the current section is limited to what can be stated without inventing market history. The live price is $353.48 as of Mar 24, 2026, but 50-day and 200-day moving averages, RSI, MACD, and support/resistance levels aren't provided. Likewise, there's no volume trend series in the authoritative inputs...

Direct implied-volatility data was not supplied, so the correct read is directional rather than numerical: the stock’s option market is likely anchored to a quality-name risk premium rather than a crash premium. That view is supported by the company’s 28.3% operating margin, 19.4% net margin, and earnings predictability score of 100, all of which typically compress realized volatility relative to weaker software peers. At the same time, the current share price of $367.34 sits far below the deterministic DCF fair value of $395.00 and even below the Monte Carlo median of $467.74...

No live tape of block trades, sweep activity, or strike-level open interest was included in the source data, so any claim about unusual options activity would be speculative. The only defensible positioning inference is derived from the equity gap itself: with the stock at $353.48 versus a DCF base fair value of $395.00, long-dated calls or call spreads are the structure most consistent with a market that wants upside exposure without paying full delta...

Short interest data was not supplied, so short interest (a portion of float), days to cover, and cost to borrow remain n/a. That matters because Roper’s balance sheet and cash profile can either suppress or amplify squeeze dynamics depending on whether shorts view the name as a quality compounder or a valuation compression trade. Using the available fundamentals, the base-case squeeze risk is Medium, not because the float is demonstrably crowded, but because the stock sits in a zone where downside hedges can remain sticky while any re-rating can force incremental covering...

Proxy-level governance provisions aren't disclosed Available data, so poison pill status, classified-board structure, dual-class share structure, voting standard, proxy access, and proposal history can't be confirmed here. Because the required DEF 14A facts are absent, this section must be treated as a data gap rather than an adverse conclusion. On the information available, the overall governance score is best described as Adequate rather than Strong or Weak...

The accounting picture is broadly constructive. In 2025, operating cash flow was $2.5403B versus net income of $1.54B, which indicates strong cash conversion rather than aggressive accrual-driven earnings. Gross margin held at 69.2% and operating margin at 28.3%, supporting the view that the business model is economically resilient and that reported profitability is not obviously inflated...

Roper scores well on the parts of Buffett’s checklist that matter most for compounding: business understandability, durability, management quality, and pricing power. The company’s 2025 audited results show 69.2% gross margin, 28.3% operating margin, and $2.54B of operating cash flow, all of which support the idea that this is a high-quality capital allocator rather than a commodity operator. The weaker point is price: at 24.9x earnings and with the stock at $353.48 versus a DCF fair value of $395.00, the market is clearly not paying a distressed multiple, so the thesis depends on compounding rather than multiple mean reversion...

Roper sits in the Maturity phase of its business cycle: it's already highly profitable, still growing, and no longer dependent on a single product or a one-time turnaround. The evidence is the 2025 audited profile of 69.2% gross margin, 28.3% operating margin, and +12.3% revenue growth YoY, alongside a modestly negative -0.8% net income growth YoY. That combination says the company is still compounding, but the next leg of value creation is likely to come from capital allocation and mix, not from a new growth regime...

Roper’s historical pattern is consistent and recognizable: deploy capital into acquired assets, preserve operating discipline, and let per-share economics compound over time. The 2025 balance sheet shows the same pattern in hard numbers, with goodwill rising to $21.34B, long-term debt rising to $9.30B, and total assets reaching $34.58B. That's classic acquisition-led expansion, not organic-only scaling, and it implies management is still using the balance sheet as a growth engine...